Kathleen Goin, Chief Operating Officer at PALVELLA THERAPEUTICS, INC. (PVLA), sold 4,302 shares at $151.39 ($655K) on 2026-08-19, disclosed to the SEC on 2026-08-20.
Scheduled sale ($655k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $151.39 | 1,500 | $227K | 34.7% |
| 2 | $151.80 | 1,998 | $303K | 46.3% |
| 3 | $153.00 | 400 | $61K | 9.3% |
| 4 | $155.59 | 102 | $16K | 2.4% |
| 5 | $156.77 | 302 | $47K | 7.2% |
| Total | $152.21 avg | 4,302 |
| $655K |
| 100% |
| Filing → |
| PVLA | SELL | 2026-06-22 | $476K | — | Filing → |
| PVLA | SELL | 2026-05-22 | $476K | — | Filing → |
| PVLA | SELL | 2026-04-17 | $547K | — | Filing → |